|
|
Vol. 17.12 – 3 July, 2025
|
|
|
|
|
|
|
|
Scientists found that bridge-like lipid transport proteins (BLTPs) facilitate the growth of a TNBC cell line and sustain its aggressiveness in an in vivo model of metastasis, suggesting that maintenance of plasma membrane fluidity by BLTP2 may be critical for tumorigenesis in humans. [Nature Cell Biology]
|
|
|
|
|
|
PUBLICATIONSListed by the impact factor of the journal
|
|
|
|
|
|
Investigators showed that autophagy normally suppresses breast cancer metastasis by enabling the clearance of NBR1–p62/SQSTM1 complexes that instruct p63-mediated pro-metastatic basal differentiation programs.
[Nature Cell Biology]
|
|
|
|
|
|
Scientists demonstrated that p95HER2, a truncated form of human epidermal growth factor receptor 2 (HER2), drives immune evasion in HER2-positive female breast cancer, enhancing tumor growth and conferring therapy resistance. [Nature Cancer]
|
|
|
|
|
|
Researchers investigated the development of pirarubicin and gemcitabine co-loaded polymeric nanoparticles for synergistic activity against breast cancer cells.
[Nanoscale Horizons]
|
|
|
|
|
|
A series of diaryl piperidone-sulfonamide derivatives were designed as dual inhibitors of STAT3/CAIX and ferroptosis inducers for TNBC.
[Journal of Medicinal Chemistry]
|
|
|
|
|
|
The specificity of a chimeric cytotoxic peptide was confirmed in vitro by testing the cytotoxic activity of breast cancer cells overexpressing CCR5, a major CCL8 receptor, and by a neutralizing anti-CCL8 antibody they developed.
[Molecular Oncology]
|
|
|
|
|
|
Macrophage type 1-derived extracellular vesicles were isolated and combined with poly(lactic-co-glycolic acid) nanoparticles loaded with the TLR3 agonist poly I:C as a therapeutic strategy to investigate their antitumor activity by downregulating tumor immune escape in the tumor microenvironment of breast cancer. [Molecular Carcinogenesis]
|
|
|
|
|
|
|
|
The authors focus on the clinical applications of circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) in breast cancer progression, relapse, diagnosis, and treatment response. [Molecular and Cellular Biochemistry]
|
|
|
|
|
|
|
|
Susan G. Komen® commended the United States Supreme Court’s decision to overturn a lower court decision that threatened access to preventive breast care services, including screening mammography, risk-reducing medications for high-risk individuals, and genetic counseling. [Susan G. Komen]
|
|
|
|
|
|
The appointment, announced by the Office of the Governor General, recognizes Dr. Whelan’s global impact on radiation oncology, particularly in the treatment of breast cancer. [McMaster University]
|
|
|
|
|
|
|
|
August 10 – 15, 2025 Newry, Maine, United States
|
|
|
|
|
|
|
|
|
|
|
University of Cambridge – Cambridge, England, United Kingdom
|
|
|
|
|
|
|
University of Pennsylvania – Philadelphia, Pennsylvania, United States
|
|
|
|
|
|
|
Princeton University – Princeton, New Jersey, United States
|
|
|
|
|
|
|
University of Southampton – Southampton, England, United Kingdom
|
|
|
|
|
|
|
University of Cambridge – Cambridge, England, United Kingdom
|
|
|
|
|
|